Microbes and Infection

Papers
(The TQCC of Microbes and Infection is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses516
Is COVID-19 receiving ADE from other coronaviruses?319
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future250
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China240
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2147
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster142
Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes135
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses126
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses106
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients93
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement93
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study92
Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency81
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases77
Could nasal nitric oxide help to mitigate the severity of COVID-19?67
Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study66
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season62
Molecular basis of COVID-19 relationships in different species: a one health perspective54
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis53
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit51
Anti-science extremism in America: escalating and globalizing41
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-1940
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China39
Current development of COVID-19 diagnostics, vaccines and therapeutics37
COVID19 meets the antivaccine movement37
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development36
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants35
Coxiella burnetii: international pathogen of mystery30
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types29
Pneumonia caused by Mycobacterium tuberculosis29
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity26
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system22
Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses – An epidemiological study based on hospital data22
Prolonged viral shedding and antibody persistence in patients with COVID-1921
Metformin promotes Mycobacterium tuberculosis killing and increases the production of human β-defensins in lung epithelial cells and macrophages19
Does the hygiene hypothesis apply to COVID-19 susceptibility?19
Cause or effect? The spatial organization of pathogens and the gut microbiota in disease17
Chloroquine paradox may cause more damage than help fight COVID-1917
Management of COVID-19: current status and future prospects17
Detection of Mayaro virus in Aedes aegypti mosquitoes circulating in Goiânia-Goiás-Brazil17
Therapeutic approaches for combating Pseudomonas aeruginosa infections16
The Pseudomonas aeruginosa HSP90-like protein HtpG regulates IL-8 expression through NF-κB/p38 MAPK and CYLD signaling triggered by TLR4 and CD9116
Digging the rabbit hole, COVID-19 edition: anti-vaccine themes and the discourse around COVID-1916
Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis15
The metaeffector MesI regulates the activity of the Legionella effector SidI through direct protein–protein interactions15
It is too soon to attribute ADE to COVID-1915
Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-1914
Coronavirus vaccine-associated lung immunopathology-what is the significance?14
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)14
COVID-19 vaccine decisions: considering the choices and opportunities13
The intestinal microbiota: from health to disease, and back13
Unraveling Ascaris suum experimental infection in humans13
Transcriptional ups and downs: patterns of gene expression in the life cycle of Toxoplasma gondii13
Combination of colistin and tobramycin inhibits persistence of Acinetobacter baumannii by membrane hyperpolarization and down-regulation of efflux pumps13
Retrograde axonal transport property of adeno-associated virus and its possible application in future12
Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes12
Intranasal immunization with chitosan microparticles enhances LACK-DNA vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis12
Characterization of reduced susceptibility to chlorhexidine among Gram-negative bacteria12
The synergistic triad between microcin, colibactin, and salmochelin gene clusters in uropathogenic Escherichia coli12
Pathogenesis and immune response in Brucella infection acquired by the respiratory route12
Anti-malarial humoral immunity: the long and short of it11
Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4+ T cell counts <350 cells/mm3 – A potential hallmark of chronic inflammation11
The fate of house cats during the COVID-19 pandemic11
Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-κB-involved serotonin and BDNF expression11
Comparative proteomics in the three major human pathogenic species of the genus Sporothrix11
Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis10
Porphyromonas gingivalis in oral squamous cell carcinoma: a review10
Dihydromyricetin is a new inhibitor of influenza polymerase PB2 subunit and influenza-induced inflammation10
The COVID-19 epidemic and other notifiable infectious diseases in China10
Enhanced expression of NLRP3 inflammasome components by monocytes of patients with pulmonary paracoccidioidomycosis is associated with smoking and intracellular hypoxemia10
The Forrest Gump approach to preventing severe COVID-19 – reverse the predisposing pro-inflammatory state with exercise10
Chlamydia psittaci in fulmars on the Faroe Islands: a causative link to South American psittacines eight decades after a severe epidemic9
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector9
N-acetyl-cysteine mediates protection against Mycobacterium avium through induction of human β-defensin-2 in a mouse lung infection model9
BFRF1 protein is involved in EBV-mediated autophagy manipulation9
Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection9
Recurrence of COVID-19 after recovery ? A case series in health care workers, France9
Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients9
COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France)9
Human mesenchymal stem cell based intracellular dormancy model of Mycobacterium tuberculosis9
COVID-19 and Fungal infections: a double debacle9
Machine learning-based investigation of the relationship between gut microbiome and obesity status8
The microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice8
Staphylococcus epidermidis small colony variants, clinically significant quiescent threats for patients with prosthetic joint infection8
Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals8
The immunopathogenesis of tuberculous pericarditis8
Substantial induction of non-apoptotic CD4 T-cell death during the early phase of HIV-1 infection in a humanized mouse model8
Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection8
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?8
COVID-19: disease, or no disease? - that is the question. It’s the dose stupid!7
The prebiotic effect of human milk oligosaccharides 3′- and 6′-sialyllactose on adhesion and biofilm formation by Clostridioides difficile – pilot study7
Characterization of Brucella abortus S19 as a challenge strain for use in a mouse model of brucellosis7
Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation7
Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-27
Airborne infection with Covid-19? A historical look at a current controversy7
Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering7
Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines7
Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza7
Effects of IgG and IgM autoantibodies on non-infected erythrocytes is related to ABO blood group in Plasmodium vivax malaria and is associated with anemia7
Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo7
Modulation of human endogenous retroviruses –H, -W and -K transcription by microbes7
Application experience of a rapid nucleic acid detection system for COVID-197
Messages from the Fourth International Conference on Clinical Metagenomics6
Clinical and genomic data of sars-cov-2 detected in maternal–fetal interface during the first wave of infection in Brazil6
Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients6
Xanthenedione (and intermediates involved in their synthesis) inhibit Zika virus migration to the central nervous system in murine neonatal models6
Defined gut microbial communities: promising tools to understand and combat disease6
A metagenomic study of the gut microbiome in PTB’S disease6
Characteristics of in vitro infection of human monocytes, by Rickettsia helvetica6
Lycopene attenuates Staphylococcus aureus-induced inflammation via inhibiting α-hemolysin expression6
TREM-1 enhances Mycobacterium tuberculosis-induced inflammatory responses in macrophages6
Deceiving the big eaters: Salmonella Typhimurium SopB subverts host cell xenophagy in macrophages via dual mechanisms6
Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages6
CD38 deficiency up-regulated IL-1β and MCP-1 through TLR4/ERK/NF-κB pathway in sepsis pulmonary injury6
The attenuation of Th1 and Th17 responses via autophagy protects against methicillin-resistant Staphylococcus aureus-induced sepsis6
Novel H7N7 avian influenza viruses detected in migratory wild birds in eastern China between 2018 and 20206
Availability of essential diagnostics at primary care public clinics in Peru6
0.058602094650269